Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ADIL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 1
17 filers reported a long position in ADIL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| JANE STREET GROUP, LLC | $82.2K | 32.1K | New |
| CITADEL ADVISORS LLC | $75.6K | 29.5K | New |
| UBS Group AG | $49K | 19.1K | +3,432.7% |
| StoneX Group Inc. | $35.7K | 19.7K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $31.7K | 12.4K | -48.9% |
| China Universal Asset Management Co., Ltd. | $20.5K | 8K | New |
| VANGUARD FIDUCIARY TRUST CO | $15.1K | 5.9K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.9K | 5.8K | +1,515.2% |
| Manchester Capital Management LLC | $4.9K | 1.9K | Unchanged |
| Tower Research Capital LLC (TRC) | $3.6K | 1.4K | +4.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.